Works by Zai, Wenjing

Results: 9

Therapeutic Opportunities of IL-22 in Non-Alcoholic Fatty Liver Disease: From Molecular Mechanisms to Clinical Applications.

Published in:

Biomedicines, 2021, v. 9, n. 12, p. 1912, doi. 10.3390/biomedicines9121912

By:

Zai, Wenjing;
Chen, Wei;
Liu, Hongrui;
Ju, Dianwen

Publication type:

Article

NOD-Like Receptor Protein 3 Inflammasome-Dependent IL-1β Accelerated ConA-Induced Hepatitis.

Published in:

Frontiers in Immunology, 2018, p. 1, doi. 10.3389/fimmu.2018.00758

By:

Luan, Jingyun;
Zhang, Xuyao;
Wang, Shaofei;
Li, Yubin;
Fan, Jiajun;
Chen, Wei;
Zai, Wenjing;
Wang, Sijia;
Wang, Yichen;
Chen, Mingkuan;
Meng, Guangxun;
Ju, Dianwen

Publication type:

Article

Perfluorocarbon Nanoparticles Mediated Platelet Blocking Disrupt Vascular Barriers to Improve the Efficacy of Oxygen‐Sensitive Antitumor Drugs.

Published in:

Small, 2018, v. 14, n. 45, p. N.PAG, doi. 10.1002/smll.201801694

By:

Zhou, Zaigang;
Zhang, Baoli;
Wang, Shushan;
Zai, Wenjing;
Yuan, Ahu;
Hu, Yiqiao;
Wu, Jinhui

Publication type:

Article

The role of autophagy in the cytotoxicity induced by trastuzumab emtansine (T-DM1) in HER2-positive breast cancer cells.

Published in:

AMB Express, 2020, v. 10, n. 1, p. 1, doi. 10.1186/s13568-020-01044-0

By:

Liu, Peipei;
Fan, Jiajun;
Wang, Ziyu;
Zai, Wenjing;
Song, Ping;
Li, Yongping;
Ju, Dianwen

Publication type:

Article

Genome-Wide Extrachromosomal Circular DNA Profiling of Paired Hepatocellular Carcinoma and Adjacent Liver Tissues.

Published in:

Cancers, 2023, v. 15, n. 22, p. 5309, doi. 10.3390/cancers15225309

By:

Ye, Jianyu;
Huang, Peixin;
Ma, Kewei;
Zhao, Zixin;
Hua, Ting;
Zai, Wenjing;
Chen, Jieliang;
Fu, Xiutao

Publication type:

Article

Dihydroquercetin ameliorated acetaminophen-induced hepatic cytotoxicity via activating JAK2/STAT3 pathway and autophagy.

Published in:

Applied Microbiology & Biotechnology, 2018, v. 102, n. 3, p. 1443, doi. 10.1007/s00253-017-8686-6

By:

Zai, Wenjing;
Chen, Wei;
Luan, Jingyun;
Fan, Jiajun;
Zhang, Xuyao;
Wu, Zimei;
Ding, Tao;
Ju, Dianwen;
Liu, Hongrui

Publication type:

Article

Optimized RNA interference therapeutics combined with interleukin-2 mRNA for treating hepatitis B virus infection.

Published in:

Signal Transduction & Targeted Therapy, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41392-024-01871-8

By:

Zai, Wenjing;
Yang, Min;
Jiang, Kuan;
Guan, Juan;
Wang, Huijing;
Hu, Kongying;
Huang, Chao;
Chen, Jieliang;
Fu, Wei;
Zhan, Changyou;
Yuan, Zhenghong

Publication type:

Article

Targeting PARP and autophagy evoked synergistic lethality in hepatocellular carcinoma.

Published in:

Carcinogenesis, 2020, v. 41, n. 3, p. 345, doi. 10.1093/carcin/bgz104

By:

Zai, Wenjing;
Chen, Wei;
Han, Yuxuan;
Wu, Zimei;
Fan, Jiajun;
Zhang, Xuyao;
Luan, Jingyun;
Tang, Shijie;
Jin, Xin;
Fu, Xiang;
Gao, Hongjian;
Ju, Dianwen;
Liu, Hongrui

Publication type:

Article

HBV sequence integrated to enhancer acting as oncogenic driver epigenetically promotes hepatocellular carcinoma development.

Published in:

Journal of Experimental & Clinical Cancer Research (17569966), 2025, v. 44, n. 1, p. 1, doi. 10.1186/s13046-025-03413-8

By:

Chen, Lu;
Li, Wenxuan;
Zai, Wenjing;
Zheng, Xiangyi;
Meng, Xianlong;
Yao, Qunyan;
Li, Wei;
Liang, Ying;
Ye, Mu;
Zhou, Kaicheng;
Liu, Mengxing;
Yang, Zhicong;
Mao, Zhanrui;
Wei, Hongyan;
Yang, Shuai;
Shi, Guoming;
Yuan, Zhenghong;
Yu, Wenqiang

Publication type:

Article